Company · CIK 0001819790 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Tarsus Pharmaceuticals, Inc. · TARS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 MForm 4 → | Sep 17, 4:47 pm EDT | David E I PyottDirector | 201 | — | — | 9,575 | — | |
| Sep 15, 2026 MForm 4 → | Sep 17, 4:22 pm EDT | Wendy L YarnoDirector | 302 | — | — | 16,956 | — | |
| Sep 15, 2026 SForm 4 → | Sep 17, 4:22 pm EDT | William J Link Ph.D.Director | 12,500 | $78.38 | $979,744 | 94,487 | −11.7% | 10b5-1 |
| Sep 15, 2026 MForm 4 → | Sep 17, 4:22 pm EDT | William J Link Ph.D.Director | 201 | — | — | 106,987 | — | 10b5-1 |
| Sep 4, 2026 SForm 4 → | Sep 9, 4:14 pm EDT | Bobak R. AzamianPresident/CEO and Board Chair, Director | 10,000 | $90.56 | $905,600 | 827,991 | −1.19% | 10b5-1 |
| Sep 4, 2026 SForm 4 → | Sep 9, 4:13 pm EDT | Elizabeth Yeu LinChief Medical Officer | 13,953 | $87.50 | $1,220,885 | 1,590 | −89.8% | 10b5-1 |
| Sep 4, 2026 SForm 4 → | Sep 9, 4:12 pm EDT | Seshadri NeervannanChief Operating Officer | 4,564 | $85.00 | $387,940 | 78,532 | −5.49% | 10b5-1 |
| Sep 2, 2026 SForm 4 → | Sep 3, 4:30 pm EDT | Bobak R. AzamianPresident/CEO and Board Chair, Director | 10,000 | $80.06 | $800,600 | 837,991 | −1.18% | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 3, 4:29 pm EDT | Elizabeth Yeu LinChief Medical Officer | 11,578 | $77.56 | $897,990 | 4,770 | −70.8% | 10b5-1 |
| Jun 17, 2026 SForm 4 → | Jun 22, 4:09 pm EDT | Bobak R. AzamianPresident/CEO and Board Chair, Director | 10,000 | $61.55 | $615,488 | 847,991 | −1.17% | 10b5-1 |
| Jun 16, 2026 SForm 4 → | Jun 17, 4:17 pm EDT | Jeffrey S FarrowSee Remarks | 14,396 | $60.95 | $877,436 | 56,801 | −20.2% | |
| Jun 15, 2026 MForm 4 → | Jun 17, 4:17 pm EDT | Jeffrey S FarrowSee Remarks | 27,881 | — | — | 71,197 | — | |
| Jun 15, 2026 SForm 4 → | Jun 17, 4:17 pm EDT | Katherine GoodrichDirector | 2,954 | $62.08 | $183,384 | 2,233 | −57.0% | 10b5-1 |
| Jun 15, 2026 SForm 4 → | Jun 17, 4:17 pm EDT | William J Link Ph.D.Director | 12,500 | $62.12 | $776,495 | 106,786 | −10.5% | 10b5-1 |
| Jun 12, 2026 MForm 4 → | Jun 16, 4:06 pm EDT | Scott W MorrisonDirector | 2,954 | — | — | 7,638 | — | |
| Jun 12, 2026 MForm 4 → | Jun 16, 4:06 pm EDT | William J Link Ph.D.Director | 2,954 | — | — | 119,286 | — | |
| Jun 12, 2026 MForm 4 → | Jun 16, 4:06 pm EDT | Bhaskar ChaudhuriDirector | 2,954 | — | — | 11,654 | — | |
| Jun 12, 2026 MForm 4 → | Jun 16, 4:05 pm EDT | Katherine GoodrichDirector | 2,954 | — | — | 5,187 | — | |
| Jun 12, 2026 MForm 4 → | Jun 16, 4:05 pm EDT | Wendy L YarnoDirector | 2,954 | — | — | 16,654 | — | |
| Jun 12, 2026 MForm 4 → | Jun 16, 4:05 pm EDT | Andrew D. GoldbergDirector | 2,954 | — | — | 19,654 | — |